BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorHoward University
About this trial
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Eligibility criteria
Qualifiers
Young adults aged 18-30 years
Diagnosis of early psychosis
Currently receiving outpatient care through an early psychosis clinic
Psychiatrically stable and deemed appropriate for participation by a treating clinician
Disqualifiers
Unable to provide informed consent
Not fluent in English
History of antisocial behavior, as assessed at baseline
Immediate risk requiring a higher level of care
Trial design
Treatments tested in this trial
- BRAVE (Behavioral Response Against Violence Engagement)
- Treatment As Usual (TAU)
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Howard University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov